News brief
On 2026-07-28, according to Xiniu Data, Vivid Dx completed seed financing, raising USD 15 million. Investors were co-lead investor Cedars-Sinai Intellectual Property, co-lead investor Oxford Science Enterprises, participating investor Jameel Investment Management Company. The company is a developer of U.S. biological technology.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年7月28日，据烯牛数据报道，Vivid Dx完成种子轮融资，金额1500万美元。投资方为Cedars-Sinai Intellectual Property、Oxford Science Enterprises领投，Jameel Investment Management Company跟投。该公司为美国生物技术研发商。